12 yr avg devices · duplicate SKUs · $48K / yr support waste · incomplete recycling certificates
Current-gen monitors and kits · consolidated consumables · $39K / yr target · documented disposition
This planning demo frames a conversation. Medline advisors can refine assumptions using device runtime, battery replacement history, disposal route, and consumable consolidation data. The goal is not to turn sustainability into a separate reporting exercise; it is to connect purchasing, biomed service, infection-control supply, and facility operations around the same installed-base facts.
For clinical teams, the most useful sustainability improvements are usually practical: fewer unsupported accessories, fewer emergency shipments, more predictable battery replacement, cleaner UDI records, and a documented route for devices that should no longer stay in patient-care areas. Medline packages those details so value analysis committees can compare environmental impact with uptime, training, and total cost of ownership.
$11,200 / yr saved by consolidating monitoring accessories, retiring unsupported devices, and documenting recycling through approved channels. The facility also reduced accessory confusion for night-shift staff because replacements were tied to a single approved family.
$3,800 / yr saved after procedure-kit rationalization reduced emergency freight, duplicate sterile packs, and short-date inventory. The review included sterile storage rules, case turnover patterns, and par-level adjustments for high-volume orthopedic days.
$5,600 / yr saved through incontinence supply standardization, caregiver training, and reorder threshold planning. Documentation covered resident-care routines, skin-protection guidance, and product substitutions that could be approved before shortages occurred.
Share facility count, product families, and replacement timing. Medline will map savings levers, documentation needs, and training implications. We can also separate quick operational wins from changes that require infection-prevention approval, biomedical validation, or contract timing review.